If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
376.50    -4.50 (-1.18%)
Bid:
374.00
Ask:
377.50
Spread: 3.50 (0.936%)
Market Cap: £1.92b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

8 Jun 2017 14:31

RNS Number : 5776H
Caledonia Investments PLC
08 June 2017
 

Caledonia Investments plc

Director/PDMR Shareholding Notification

 

Caledonia Investments plc ("Caledonia") has been notified pursuant to the requirements of the EU Market Abuse Regulations of the following transactions involving three of its directors, Jamie Cayzer-Colvin, Stephen King and William Wyatt as detailed below.

 

On 6 June 2017, ordinary 5p shares were transferred to the above-named directors under Caledonia's 2011 Deferred Bonus Plan ("Deferred Bonus Plan") and 2011 Performance Share Scheme ("Performance Share Scheme"), at nil cost. On the same date, Mr Cayzer-Colvin exercised options under Caledonia's 2005 Executive Share Option Scheme ("Executive Share Option Scheme") at an exercise price of 1446p. All resulting shares were sourced from the Caledonia Investments plc Employee Share Trust and subsequently sold at 2910p per share on the same date.

 

Deferred Bonus Plan

No of shares transferred under the Deferred Bonus Plan at £nil

 

% of issued capital

No of shares sold

JMB Cayzer-Colvin

 

11,302

0.02

11,302

SA King

13,365

0.02

13,365

WP Wyatt

 

18,837

0.03

18,837

 

Performance Share Scheme

No of shares transferred under the Performance Share Scheme at £nil

 

% of issued capital

No of shares sold

JMB Cayzer-Colvin

 

19,749

0.04

19,749

SA King

11,194

0.02

11,194

WP Wyatt

 

15,776

0.03

15,776

 

 

Executive Share Option Scheme

No of options exercised under the Executive Share Option Scheme at 1446p

 

% of issued capital

No of shares sold

JMB Cayzer-Colvin

12,707

0.02

12,707

 

Further information required by the EU Market Abuse Regulations in relation to these transactions is set out in the appendix below.

Enquiries:

Mrs K M Burwood

Deputy Company Secretary

Caledonia Investments plc

+ 44 20 7802 8080

8 June 2017

 

APPENDIX 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

James Michael Beale Cayzer-Colvin

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Caledonia Investments plc

b)

 

LEI

 

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 5p shares

 

 

GB0001639920

 

b)

 

Nature of the transaction

 

 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Exercise of options with an exercise price of £14.46

3. Call of Deferred Bonus Plan ("DBP") awards

4. Sale of all shares

 

 

c)

 

 

 

Price(s) and volume(s)

 

 

1. Exercise of PSS awards

 

2. Exercise of options

 

3. Call of DBP awards

 

4. Sale of shares

 

 

 

Price(s)

 

Volume(s)

£0.00

 

19,749

 

£14.46

12,707

£0.00

11,302

£29.10

43,758

d)

 

Aggregated information

 

- Aggregated volume

 

 

 

 

 

- Price

 

 

 

 

Exercise of PSS awards, exercise of options with an exercise price of £14.46 and call of DBP awards: 43,758

 

Sale of shares: 43,758

 

Exercise of PSS awards (£nil), exercise of options with an exercise price of £14.46 (£14.46) and call of DBP awards (£nil): weighted average price £4.20

 

Sale of shares: £29.10

 

e)

 

Date of the transaction

 

 

6 June 2017

f)

 

Place of the transaction

 

 

Exercise of PSS awards, options with an exercise price of £14.46 and call of DBP awards - outside a trading venue

Sale of shares - London Stock Exchange XLON

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Stephen Anthony King

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Caledonia Investments plc

b)

 

LEI

 

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary 5p shares

 

 

GB0001639920

 

b)

 

Nature of the transaction

 

 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Call of Deferred Bonus Plan ("DBP") awards

3. Sale of all shares

 

 

Price(s) and volume(s)

 

 

 

1. Exercise of PSS awards

 

2. Call of DBP awards

 

3. Sale of shares

 

 

 

Price(s)

 

Volume(s)

£0.00

 

11,194

 

£0.00

13,365

£29.10

24,559

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

 

 

- Price

 

 

 

 

Exercise of PSS awards and call of DBP awards: 24,559

 

Sale of shares: 24,559

 

Exercise of PSS awards and call of deferred shares: £nil

 

Sale of shares: £29.10

 

e)

 

Date of the transaction

 

 

6 June 2017

f)

 

Place of the transaction

 

 

Exercise of PSS awards and call of DBP awards - outside a trading venue

 

Sale of shares - London Stock Exchange XLON

 

 

 

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

William Penfold Wyatt

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Caledonia Investments plc

b)

 

LEI

 

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary 5p shares

 

 

GB0001639920

 

b)

 

Nature of the transaction

 

 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Call of Deferred Bonus Plan ("DBP") awards

3. Sale of all shares

 

c)

 

 

Price(s) and volume(s)

 

1. Exercise of PSS awards

 

2. Call of DBP awards

 

3. Sale of shares

 

 

 

Price(s)

 

Volume(s)

£0.00

 

15,776

 

£0.00

18,837

£29.10

34,613

 

 

 

 

 

d)

 

 

 

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

Exercise of PSS awards and call of DBP awards: 34,613

 

Sale of shares: 34,613

 

 

Exercise of PSS awards and call of deferred shares: £nil

 

Sale of shares: £29.10

 

e)

 

Date of the transaction

 

 

6 June 2017

f)

 

Place of the transaction

 

 

Exercise of PSS awards and call of DBP awards - outside a trading venue

 

Sale of shares - London Stock Exchange XLON

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSSUFDAFWSEEM
Date   Source Headline
12th Jul 20164:31 pmRNSDirector/PDMR Shareholding
12th Jul 20164:29 pmRNSDirector/PDMR Shareholding
12th Jul 201612:18 pmRNSForm 8.3 - Avanti Communications Group plc
11th Jul 20164:54 pmRNSDirector/PDMR Shareholding
6th Jul 201612:38 pmRNSInterim Management Statement
6th Jul 201610:43 amRNSAcquisition
6th Jul 20167:00 amRNSNet Asset Value(s)
1st Jul 20168:19 amRNSBlock listing Interim Review
14th Jun 20168:50 amRNSAnnual Financial Report
6th Jun 20163:44 pmRNSNet Asset Value(s)
2nd Jun 20164:07 pmRNSDirector/PDMR Shareholding
27th May 20163:34 pmRNSDirector/PDMR Shareholding
27th May 20163:26 pmRNSDirector/PDMR Shareholding
27th May 20162:00 pmRNSHolding(s) in Company
26th May 20165:44 pmRNSRelated party transaction
19th May 20167:00 amRNSFinal Results 31 March 2016
9th May 20169:12 amRNSNet Asset Value(s)
4th May 20169:47 amRNSHolding(s) in Company
3rd May 201610:53 amRNSDisposal
8th Apr 20162:02 pmRNSDirector/PDMR Shareholding
7th Apr 201612:10 pmRNSNet Asset Value(s)
5th Apr 201612:50 pmRNSHolding(s) in Company
30th Mar 20162:05 pmRNSTransaction in Own Shares
23rd Mar 201611:54 amRNSDirector/PDMR Shareholding
16th Mar 20164:42 pmRNSDirector/PDMR Shareholding
8th Mar 20163:58 pmRNSDirectorate Change
4th Mar 20169:20 amRNSNet Asset Value(s)
24th Feb 20167:00 amRNSDividend Declaration
22nd Feb 20169:45 amRNSHome Member State Disclosure
4th Feb 20169:41 amRNSNet Asset Value(s)
18th Jan 20162:07 pmRNSDirector/PDMR Shareholding
7th Jan 20162:34 pmRNSInterim Management Statement
7th Jan 20162:23 pmRNSNet Asset Value(s)
4th Jan 20169:49 amRNSBlocklisting Interim Review
21st Dec 20157:00 amRNSAcquisition
8th Dec 20158:14 amRNSHalf Yearly Report
7th Dec 20159:08 amRNSNet Asset Value(s)
19th Nov 20157:00 amRNSHalf Yearly Report
9th Nov 20159:28 amRNSNet Asset Value(s)
26th Oct 20157:00 amRNSAcquisition
7th Oct 20152:20 pmRNSNet Asset Value(s)
30th Sep 20155:26 pmRNSTransaction in Own Shares
29th Sep 20154:18 pmRNSDirector/PDMR Shareholding
28th Sep 20158:12 amRNSDisposal
7th Sep 20153:20 pmRNSNet Asset Value(s)
7th Sep 201512:40 pmRNSAcquisition
1st Sep 201512:45 pmRNSChange of Registered Office
7th Aug 20159:26 amRNSNet Asset Value(s)
29th Jul 201511:32 amRNSForm 8.3 - Quintain Estates & Development
23rd Jul 20154:47 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.